Santhera Pharmaceuticals and Idis

Neuromuscular Disease Treatment Catena(R) Available in Europe on a Named Patient Basis

Liestal, Switzerland and Weybridge, England (ots/PRNewswire) -- - Santhera and Idis Partner to Facilitate Patient Access to Friedreich's Ataxia Drug Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on orphan neuromuscular diseases and Idis announced today that Catena(R) will be made available on a named patient basis in Europe. ...